The role of heregulin‐α as a motility factor and amphiregulin as a growth factor in wound healing
- 8 October 2002
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 198 (4) , 523-533
- https://doi.org/10.1002/path.1240
Abstract
Wound healing is a complex process of which growth and motility are essential features. The aim of this study was to search for keratinocyte-derived secreted factors that may play a role in these mechanisms, and their corresponding receptors. Growth and motility factors were purified from conditioned medium from cultured primary keratinocytes. Receptor and growth factor expression profiles were investigated by immunohistochemical, western blotting, and in situ hybridization analysis on cultured keratinocytes and tissue sections derived from chronic wounds. The most potent autocrine growth factor for keratinocytes, which it was possible to purify and sequence from keratinocyte-conditioned medium, is amphiregulin. Its receptor HER-1 is up-regulated on the membranes of keratinocytes lining the edge of the wound. From the same keratinocyte-conditioned medium, heregulin-α was purified as a potent motility factor for keratinocytes. Its receptor is HER-3, which is up-regulated on the membranes of keratinocytes lining the edge of the wound and on keratinocytes that had migrated towards the centre of the wound. HER-4 — another receptor for heregulin-α — is weakly present in occasional cells near the edge of the wound. The co-receptor for HER-3 and HER-4 is HER-2/neu, which is also present in epidermal cells but not overexpressed. This study shows that heregulin-α is a potent motility factor for normal epithelial cells and that it plays a central role in the process of wound healing of stratified epithelia. Heregulin-α has already been shown to be the motility factor leading to migration of HER-2/neu-overexpressing breast cancer cells. The role of amphiregulin as a growth factor and of heregulin-α as a motility factor for keratinocytes in epidermal and mucosal wound healing parallels their motility and growth induction in carcinogenesis. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 36 references indexed in Scilit:
- Epidermal growth factor.Published by Elsevier ,2021
- Pathogenesis of Paget's Disease: Epidermal Heregulin- , Motility Factor, and the HER Receptor FamilyJNCI Journal of the National Cancer Institute, 2000
- Heregulin induces tyrosine phosphorylation of HER4/p180erbB4Nature, 1993
- Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.Proceedings of the National Academy of Sciences, 1993
- Theneu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patientsInternational Journal of Cancer, 1990
- PREDICTIVE VALUE OF EGF RECEPTOR IN BREAST CANCERThe Lancet, 1988
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988
- Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.Proceedings of the National Academy of Sciences, 1987
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987